AdvaMed questions public data for product coverage
This article was originally published in Clinica
AdvaMed has drafted criteria for Medicare to use in deciding whether to accept external data by the public to verify or amend reimbursement rates. The Centers for Medicare & Medicaid Services (CMS) currently uses external data only on rare occasions, and the trade group wants the agency to better explain what data it finds most useful.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.